Details
Description
This analysis investigates the comparative risk of thromboembolic stroke, intracranial hemorrhage, gastrointestinal bleeding, and major extracranial bleeding outcomes among dabigatran, rivaroxaban, and apixaban users aged under 65 years with non-valvular atrial fibrillation in the Sentinel Distributed Database (SDD).
The study period included data from October 19, 2010 to February 29, 2020.
The analytic package associated with this analysis can be found externally in Sentinel's Git Repository located here. The Git Repository serves as Sentinel's version control tracking system for analytic packages and technical documentation.